Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer

Zhixin Ling1,2, Xiaoyan Wang3, Tao Tao4

  • 1Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, China.

Abstract

Insights

MicroRNA-193a (miR-193a) suppresses prostate cancer (PCa) progression. A feedback loop involving HOTAIR, EZH2, and miR-193a drives PCa development and may offer a therapeutic target.

Area of Science:

  • Molecular Oncology
  • Epigenetics
  • Cancer Therapeutics

Background:

  • Androgen deprivation therapy is standard for prostate cancer (PCa), but castration-resistant PCa (CRPC) remains a major cause of mortality.
  • Understanding novel molecular mechanisms driving PCa progression is crucial for developing effective targeted therapies.
  • This study investigates the HOTAIR/EZH2/miR-193a feedback loop in PCa progression.

Purpose of the Study:

  • To elucidate the function and regulatory mechanism of the HOTAIR/EZH2/miR-193a feedback loop in prostate cancer.
  • To identify miR-193a as a potential tumor suppressor in PCa.
  • To explore the therapeutic potential of targeting this feedback loop.

Main Methods:

  • Analysis of MSKCC and TCGA datasets for miR-193a expression profiles in PCa.
  • In vitro assays (CCK-8, colony formation, migration, invasion, flow cytometry) and in vivo xenograft models to assess miR-193a function.
  • Molecular techniques including plasmid/lentivirus/siRNA transfection, luciferase reporter assays, chromatin immunoprecipitation, qRT-PCR, in situ hybridization, and immunohistochemistry to determine regulatory mechanisms.

Main Results:

  • miR-193a was significantly downregulated in metastatic PCa.
  • Overexpression of miR-193a inhibited PCa cell growth, migration, invasion, and xenograft tumor growth, while promoting apoptosis.
  • HOTAIR and EZH2 repressed miR-193a expression via H3K27 trimethylation; miR-193a directly targeted HOTAIR, forming an autoregulatory feedback loop inversely correlated with HOTAIR and EZH2 expression.

Conclusions:

  • miR-193a functions as a tumor suppressor in castration-resistant prostate cancer.
  • The autoregulatory feedback loop involving HOTAIR, EZH2, and miR-193a is a key mechanism in PCa development.
  • Targeting this aberrant feedback loop presents a potential therapeutic strategy for PCa.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.7K